Watch for Adbry, Cibinqo, and Rinvoq for Eczema

March 2022

More meds for moderate to severe atopic dermatitis will try to squeeze into the market...Adbry, Cibinqo, and Rinvoq.

Save these specialty meds for when topicals (steroids, etc) aren’t enough. Include these in the EHR, even if you’re not prescribing them.

Adbry (tralokinumab) is similar to Dupixent (dupilumab). Both are injectable monoclonal antibodies that reduce inflammation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote